People | January 13, 2022
Merck KGaA appoints Global R&D Head & CSO for healthcare business sector
Danny Bar-Zohar will become Global Head of R&D and Joern-Peter Halle will become Chief Strategy Officer
Danny Bar-Zohar will become Global Head of R&D and Joern-Peter Halle will become Chief Strategy Officer
Under the terms of the agreement, Arrakis will lead research activities for the identification of RNA-targeted small molecule (rSM) binders against a broad set of targets nominated by Amgen
Simulated Moving Bed (SMB) technology is a highly engineered process for implementing chromatographic separation
JBI-802 is a novel, oral, potent and selective dual inhibitor of two epigenetic targets of the CoREST complex: LSD1 and HDAC6
Partnering to build biosynthesis processes and a pharmaceutical production platform
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
Syngene will also build and operate a new dedicated drug development laboratory to accelerate the advancement of Amgen R&D projects
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
He has more than 285 publications with 7,600 citations, 80 students have already been awarded Ph. D. degree under his able guidance and 20 postdoctoral associates have worked in his group
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
Subscribe To Our Newsletter & Stay Updated
